Orris

Treatment for HLA-B27 positive

Reading File
Finding Sources
Searching PubMed

HLA-B27 AND spondyloarthritis

Searching the Web

HLA-B27 positive treatment spondyloarthritis patient guidance

HLA-B27 positivity itself does not need treatment. It is a genetic marker, not a diagnosis. Many people who carry HLA-B27 never develop disease.
Treatment depends on whether you have an associated condition, most commonly:
  • Axial spondyloarthritis / ankylosing spondylitis
  • Acute anterior uveitis (painful red eye with light sensitivity)
  • Reactive arthritis
  • Psoriatic arthritis or inflammatory bowel disease-related arthritis
If you have inflammatory back pain or confirmed spondyloarthritis, management usually includes:
  1. Regular exercise and physiotherapy - posture, spinal mobility, strengthening.
  2. NSAIDs such as naproxen, ibuprofen, or celecoxib, if safe for you.
  3. If inflammation remains active, a rheumatologist may use biologic therapy, commonly TNF inhibitors or IL-17 inhibitors.
  4. Local steroid injections can help selected inflamed joints or tendon insertions. Long-term oral steroids are generally avoided for axial disease.
  5. Treat related eye, skin, or bowel disease with the appropriate specialist.
Arrange assessment with a rheumatologist if you have back/buttock pain lasting over 3 months that improves with activity, morning stiffness, swollen joints, heel pain, psoriasis, recurrent diarrhea, or a family history of spondyloarthritis. HLA-B27 is only one part of diagnosis, together with symptoms, examination, inflammatory markers, and sometimes sacroiliac-joint MRI.
Seek urgent same-day eye care for a painful red eye, blurred vision, or marked light sensitivity, because HLA-B27-associated uveitis requires prompt treatment.
This is a shared conversation. Sign in to Orris to start your own chat.